Hanoi (VNA) – A meeting was held at the Hanoi Lung🥂 Hospital on March 24 in response to World Tuberculosis Day.
The event aims to call on the public to join in activities to prevent tuberculosis (TB) and lung disease.
Director of the hospital Pham Huu Thuong said Hanoi is stepping up anti-TB programmes across the city and will ensure sufficient medicines and health equipment.
In addition to raising public awareness of TB prevention, the capital will also enhance local access to medical check-up and treatment, especially for poor people and TB and HIV patients.
Health authorities will employ new hi-tech measures to detect and treat TB patients.
In 2015, Hanoi Lung Hospital treated 2,650 TB patients. From December 2015, the hospital piloted treatment for 30 patients suffering from multi drug-resistance (XDR) TB bacteria. Their health status is developing well, Thuong said.
The hospital also focused on improving infrastructure to prevent bacterial contamination, he added.
Vietnam is striving to reduce the rate of tuberculosis (TB) patients to 131 cases/100,000 people and the fatality rate to lower than 10/100,000 people by 2020, according to the National Tuberculosis Programme.
The World Health Organisation (WHO) said TB is the second leading infectious cause of death while XDR is present in almost all countries.
The symptoms of active lung TB are coughing, sometimes with sputum or blood, chest pains, weakness, weight loss, fever and night sweats. Tuberculosis is treatable with a six-month course of antibiotics.-VNA
The National Tuberculosis Control Programme (NTP) aims to reduce the TB incidence rate to 187 per 100,000 people and the fatality rate to below 18 per 100,000 in 2015, based on its encouraging outcomes in the previous year.
While there were few new cases of tuberculosis in Hanoi last year, a strain of the disease resistant to a variety of drugs had complicated treatment, health experts said at a recent conference.
A project will bolster community-based malaria prevention and control through 2017, with the backing of the Global Fund to Fight AIDS, Tuberculosis and Malaria.
The Can Tho city hospital for tuberculosis (TB) and pulmonary diseases, the most advanced of its kind in the Mekong Delta, was ready to serve patients on February 19.
Vietnam is striving to reduce the rate of tuberculosis (TB) patients to 131 cases/100,000 people and the fatality rate from the disease to lower than 10/100,000 people by 2020.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative photo (Photo: Ha Noi Moi)
